CA Stock MarketDetailed Quotes
CPH Cipher Pharmaceuticals Inc
- 15.235
- +0.195+1.30%
15min DelayMarket Closed Nov 1 16:00 ET
389.84MMarket Cap12.38P/E (TTM)
15.460High15.150Low19.28KVolume15.150Open15.040Pre Close295.21KTurnover19.69052wk High0.13%Turnover Ratio25.59MShares4.30052wk Low1.231EPS TTM220.80MFloat Cap19.690Historical High14.36P/E (Static)14.49MShs Float0.260Historical Low1.061EPS LYR2.06%Amplitude--Dividend TTM3.15P/B1Lot Size--Div YieldTTM
Cipher Pharmaceuticals Inc Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0.30%5.3M | 20.08%5.87M | 2.36%21.16M | 0.22%4.92M | 26.63%6.07M | -4.86%5.29M | -9.79%4.89M | -5.78%20.68M | -16.11%4.91M | 6.16%4.79M |
| Operating revenue | 0.30%5.3M | 20.08%5.87M | 2.36%21.16M | 0.22%4.92M | 26.63%6.07M | -4.86%5.29M | -9.79%4.89M | -5.78%20.68M | -16.11%4.91M | 6.16%4.79M |
| Cost of revenue | 4.24%1.11M | 7.98%1.06M | 1.93%4.07M | 2.03%955K | 25.12%1.08M | -1.03%1.06M | -13.08%977K | 8.36%3.99M | 0.43%936K | 8.72%860K |
| Gross profit | -0.69%4.2M | 23.10%4.81M | 2.46%17.09M | -0.20%3.97M | 26.96%4.99M | -5.77%4.23M | -8.92%3.91M | -8.63%16.68M | -19.25%3.97M | 5.61%3.93M |
| Operating expense | -5.41%1.61M | 12.41%1.76M | 25.33%7.06M | 13.92%1.6M | 14.34%1.97M | 52.28%1.7M | 12.20%1.56M | 8.33%5.63M | 36.68%1.4M | 1.12%1.72M |
| Selling and administrative expenses | 6.81%1.27M | 20.08%1.42M | 22.57%5.39M | 25.00%1.24M | 14.84%1.55M | 28.82%1.19M | 1.02%1.19M | -13.93%4.4M | -3.22%992K | -20.85%1.35M |
| -General and administrative expense | 6.81%1.27M | 20.08%1.42M | 22.57%5.39M | 25.00%1.24M | 14.84%1.55M | 28.82%1.19M | --1.19M | --4.4M | --992K | --1.35M |
| Research and development costs | -72.35%47K | 28.57%45K | 80.33%440K | 22.06%83K | 322.22%152K | 335.90%170K | -46.15%35K | 177.27%244K | --68K | --36K |
| Depreciation amortization depletion | -14.62%292K | -15.74%289K | 24.06%1.23M | -19.94%273K | -20.41%269K | 120.65%342K | 121.29%343K | --989K | --341K | --338K |
| -Depreciation and amortization | -14.62%292K | -15.74%289K | 24.06%1.23M | -19.94%273K | -20.41%269K | 120.65%342K | 121.29%343K | --989K | --341K | --338K |
| Operating profit | 2.49%2.59M | 30.22%3.06M | -9.20%10.03M | -7.89%2.37M | 36.79%3.02M | -25.02%2.53M | -19.08%2.35M | -15.38%11.05M | -33.97%2.57M | 9.41%2.21M |
| Net non-operating interest income (expenses) | 43.09%611K | 56.34%555K | 303.02%1.87M | 107.87%555K | 239.49%533K | 1,193.94%427K | 4,971.43%355K | 680.00%464K | 6,575.00%267K | 1,844.44%157K |
| Non-operating interest income | 43.09%611K | 56.34%555K | 303.02%1.87M | 107.87%555K | 239.49%533K | 1,193.94%427K | 4,971.43%355K | --464K | --267K | --157K |
| Other net income (expenses) | -415.67%-685K | -9,271.43%-642K | 2,322.86%778K | 696.84%757K | -502.78%-434K | 389.33%217K | -58.82%7K | 98.18%-35K | 493.75%95K | 89.71%-72K |
| Gain on sale of security | -189.51%-401K | -9,271.43%-642K | 2,322.86%778K | 696.84%757K | -502.78%-434K | 697.33%448K | -58.82%7K | -139.77%-35K | 493.75%95K | -224.14%-72K |
| Special income (charges) | -22.94%-284K | ---- | ---- | ---- | ---- | ---231K | ---- | ---- | ---- | ---- |
| -Less:Restructuring and mergern&acquisition | 22.94%284K | ---- | ---- | ---- | ---- | --231K | ---- | ---- | ---- | ---- |
| Income before tax | -20.66%2.52M | 9.60%2.97M | 10.47%12.68M | 25.46%3.68M | 36.03%3.12M | -4.72%3.17M | -7.36%2.71M | 3.80%11.48M | -25.06%2.93M | 75.06%2.3M |
| Income tax | -584.85%-480K | -2,484.15%-1.96M | 49.19%-7.7M | 76.27%-3.97M | -988.86%-3.91M | -91.57%99K | -89.41%82K | -559.16%-15.16M | -1,615.57%-16.75M | -169.71%-359K |
| Earnings from equity interest net of tax | ||||||||||
| Net income | -2.47%3M | 87.47%4.92M | -23.48%20.38M | -61.10%7.66M | 164.92%7.03M | 42.70%3.07M | 22.20%2.63M | 243.34%26.64M | 600.39%19.68M | 233.42%2.65M |
| Net income continuous operations | -2.47%3M | 87.47%4.92M | -23.48%20.38M | -61.10%7.66M | 164.92%7.03M | 42.70%3.07M | 22.20%2.63M | 243.34%26.64M | 600.39%19.68M | 233.42%2.65M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -2.47%3M | 87.47%4.92M | -23.48%20.38M | -61.10%7.66M | 164.92%7.03M | 42.70%3.07M | 22.20%2.63M | 243.34%26.64M | 600.39%19.68M | 233.42%2.65M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -2.47%3M | 87.47%4.92M | -23.48%20.38M | -61.10%7.66M | 164.92%7.03M | 42.70%3.07M | 22.20%2.63M | 243.34%26.64M | 600.39%19.68M | 233.42%2.65M |
| Diluted earnings per share | 0.00%0.12 | 110.00%0.21 | -21.90%0.82 | -58.97%0.32 | 154.55%0.28 | 50.00%0.12 | 25.00%0.1 | 262.07%1.05 | 680.00%0.78 | 266.67%0.11 |
| Basic earnings per share | 0.00%0.12 | 100.00%0.2 | -22.33%0.8 | -60.53%0.3 | 170.00%0.27 | 50.00%0.12 | 25.00%0.1 | 255.17%1.03 | 660.00%0.76 | 233.33%0.1 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data